It is essential to eliminate IgM-class antibodies as they are responsible for anti-A and anti-B antibody-mediated intravascular hemolysis [24]; however, the loss of the IgA isotype may weaken the protective potential of the plasma-derived product tested in current study [25]. This evidence concerns the gene CD79A and hemolysis.